Comprehensive Survival Analysis of a Cohort of Patients with Stevens Johnson Syndrome and Toxic Epidermal Necrolysis
Autor: | Ariane Dunant, Sylvia H. Kardaun, Alexis Sidoroff, Yvonne Liss, Luigi Naldi, Sima Halevy, Martin Schumacher, Maja Mockenhaupt, Jan Nico Bouwes Bavinck, Peggy Sekula, Jean-Claude Roujeau |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
Adult
Male medicine.medical_specialty Population Dermatology Biochemistry CLASSIFICATION Cohort Studies MULTIFORME Risk Factors Internal medicine medicine Humans Registries Risk factor education Molecular Biology Survival analysis Aged education.field_of_study business.industry Mortality rate Hazard ratio LYELL SYNDROME Disease Management Cell Biology Middle Aged medicine.disease Confidence interval Toxic epidermal necrolysis Surgery Survival Rate SEVERITY Stevens-Johnson Syndrome Cohort Female business FOLLOW-UP BURN CENTER Follow-Up Studies |
Zdroj: | Journal of Investigative Dermatology, 133(5), 1197-1204. ELSEVIER SCIENCE INC Journal of Investigative Dermatology, 133(5), 1197-1204 |
ISSN: | 0022-202X |
Popis: | Stevens Johnson syndrome and toxic epidermal necrolysis are severe cutaneous adverse reactions that are of major concern because of high mortality rates. On the basis of data collected in the RegiSCAR study, the aim was to assess risk factors (including modalities of patient management) for mortality, regardless of the cause, up to 1 year after the reaction. Within this cohort, the mortality rate was 23% (95% confidence interval (Cl) 19-27%) at 6 weeks and 34% (95% Cl 30-39%) at 1 year. Severity of reaction was a risk factor for mortality only in the first 90 days after onset, whereas serious comorbidities and age influenced mortality beyond 90 days and up to 1 year after onset of reaction. The risk of death for patients with identified drug cause was borderline lower than for patients with a reaction of unknown cause (hazard ratio 0.66, 95% Cl 0.45-0.96). The study could not provide conclusive evidence regarding patient management. This large-scale population-based follow-up study of such patients confirmed high in-hospital mortality and revealed a remarkable number of deaths after discharge, which could mainly be attributed to severe comorbidities and older age, whereas the impact of severity of reaction on the risk of death was limited to the first few weeks. |
Databáze: | OpenAIRE |
Externí odkaz: |